Semmer Clothing, whose online revenue exceeded 50% in the second quarter, transferred the French children’s clothing brand acquired for 800 million to its major shareholder
In May 2018, it cost approximately 110 million euros (approximately RMB 844 million) to acquire 100% of the equity and debt of SofizaSAS to reach Zhejiang Semir Clothing Co., Ltd. (hereinafter referred to as “Semi Clothing”), which acquired all the assets of Kidiliz Group, has taken a big step to give up the assets.
On July 21, Semir Clothing) received a letter of concern from the Shenzhen Stock Exchange. Regarding the announcement of its sale in just about two years, the Shenzhen Stock Exchange required Semir Clothing to provide details. Explain the reasons and rationality for selling the subsidiary, and explain the creditor-debt relationship between Semir Apparel and Sofiza, the status of capital investment in Sofiza during its holding period, etc.
On the evening of July 20, Semir Clothing issued an announcement announcing its intention to sell a wholly-owned subsidiary to Semir Group Co., Ltd. (hereinafter referred to as “Semi Group”), a person acting in concert with its controlling shareholder. 100% of the assets and operations of French Sofiza. The specific sales price and transaction time have not been determined. Semir Group promises that during the period of holding Sofiza’s asset interests, Sofiza’s assets will not develop new business operations or expand the original business in China. If it violates its commitment, the operating profits or additional income will be donated to Semir Apparel free of charge.
As for the reason for the sale, Semir Clothing explained that in the past two years, due to the continued economic downturn in Europe, the revenue of Kidiliz Group’s main brand business has continued to decline, and the number of stores has decreased year by year. The business losses are serious and the losses are amplifying. Especially after the outbreak of the epidemic, Kidiliz Group’s main business areas France and Italy and the entire European market economy suffered heavy losses, which adversely affected the company’s performance. In order to avoid the impact of this business on the company’s performance, Due to continued adverse effects, the company plans to sell the assets and business.
Public information shows that Sofiza was registered in France in 2005 with a registered capital of 251 million euros. Semir Clothing earlier It has been said that the French high-end children’s clothing group Kidiliz Group owned by Sofiza and its own children’s clothing business have clear complementarity in brand positioning and main markets, and have integration effects in value chains such as product design and research and development, international market operations and global procurement. The acquisition Sofiza helps improve the company’s overall attractiveness and bargaining power in the channel, and optimizes overall operating costs.
The reporter had previously learned from Semir Apparel that developing the Chinese business of Kidiliz’s brands Catimini and Absorba was the biggest starting point for the Kidiliz Group acquisition project at that time. At present, Catimini and Absorba have opened 6 stores and 2 stores in China respectively, and have carried out cross-border cooperation with the Balabala brand, and the overall effect is not bad. The pressure on overseas business development has been relatively high recently. Based on the impact on the company’s financial statements, the management of Semir Apparel will make strategic adjustments and take appropriate measures to actively promote the healthy development of the company’s business.
The financial report shows that Semir Apparel began to consolidate 100% of the equity of French Sofiza company in October 2018, and consolidated the company’s fourth quarter of 2018, full year of 2019, and 2020 Operating income in the first quarter was 795 million yuan, 3.024 billion yuan, and 560 million yuan respectively, and total profits were -48.84 million yuan, -307 million yuan, and -121 million yuan respectively. It has continued to suffer losses since the acquisition and consolidation. In 2019, its losses accounted for 10% of the company’s total. 20% of the net profit attributable to the parent company. In the first quarter of 2020, the company and the company’s original business profits were -121 million yuan and 139 million yuan respectively. Kidiliz has a greater drag on the company’s performance.
In addition, considering that the foreign epidemic situation is not obvious in the first quarter, and the foreign epidemic situation begins to ferment in the second quarter, it is estimated that Kidiliz’s losses will increase significantly compared with the first quarter. Semir Apparel forecasts that net profit attributable to its parent company in the first half of the year fell by 90-100% year-on-year. In addition to the decline in profits from the original business in China, Kidiliz’s increasing losses also had a greater impact.
The reason for its loss is that on the one hand, Kidliiz already suffered losses due to poor management before being acquired by Semir Clothing, with a loss of approximately RMB 200 million in 2017; on the other hand, after the acquisition, Kidliiz Because the company’s main business is located in Europe, the brand is still undergoing adjustment due to the economic downturn in the local market, stores have been reduced year by year, and revenue has declined, resulting in losses that have not been improved. In addition, the company intends to help it expand the Chinese market, but it is a drop in the bucket and has little impact on the overall performance. On the other hand, the continued spread of the COVID-19 epidemic in Europe since 2020 and the corresponding worsening of its macroeconomic and consumer demand have once again increased the difficulty and pressure on the company to integrate it, and the adverse impact on the company’s performance has increased. And the time is lengthening, prompting the company to make this decision to sell assets.
Spent 179 million yuan to acquire shares of the women’s clothing brand Langzi. In the first half of the year, it lost more than 3 million yuan due to the epidemic!
Langzi Co., Ltd. (hereinafter referred to as “Langzi Co., Ltd.”) announced on the evening of July 21 that the company’s wholly-owned subsidiary Langzi Medical Management Co., Ltd. (hereinafter referred to as “Langzi Medical”) jointly signed a relevant equity transfer agreement with Zhang Yongqiang, Li Tao and others, and planned to acquire Sichuan Milan Baiyu Medical Cosmetic Hospital Co., Ltd., Shenzhen Milan Baiyu Medical Cosmetology Clinic, and Sichuan Jing with RMB 178.8 million of Langzi Medical’s own funds. The remaining 30% equity interests of six holding subsidiaries including Dermatology Medical Cosmetic Hospital Co., Ltd., Xi’an Jingfu Medical Cosmetology Co., Ltd., Changsha Furong District Jingfu Medical Cosmetology Co., Ltd. and Chongqing Jingfu Medical Cosmetology Co., Ltd. (hereinafter referred to as “the Acquisition”), after the completion of this acquisition, Langzi Medical will hold 100% of the equity of the above six companies.
Langzi shares stated that this acquisition aims to further promote the company’s “pan-fashion industry interconnected ecosystem” strategy, enhance control of existing medical beauty institutions and follow-up medical beauty brands lay the foundation for expansion and enhance the company’s performance.
The reporter learned here that Langzi Co., Ltd. has officially entered the medical beauty business by acquiring the controlling stake of the target company in 2016. From clothing beauty to facial beauty, it focuses on women’s fashion consumption needs, especially their pursuit of beauty. In recent years, through connotative growth, Langzi Medical Beauty has gradually improved its brand profitability; through extensive expansion, its business scale has continued to expand, and its overall performance has increased year by year. With more than four years of operation management and experience accumulation, Langzi Medical Aesthetics has established a dominant position in regional medical aesthetics, and has formed a high-end (Milan Baiyu), technology (Gao Yisheng), and light medical aesthetics multi-store chain (Jingjing) in brand building. three-dimensional pattern of skin).
Through operations in recent years, Langzi has initially formed a “1+N” industrial layout in Chengdu and Xi’an, the two core cities in the west, that is, building a company in a specific area Or a medical beauty institution system consisting of multiple large plastic surgery hospitals and several small chain outpatient clinics/clinics.
Langzi shares stated that the six target companies controlled by the company, including Sichuan Milan, Shenzhen Milan, Sichuan Jingfu, Xi’an Jingfu, Changsha Jingfu and Chongqing Jingfu, serve as their own An important institution for the launch of medical beauty, it has realized the strategic layout of the company’s “pan-fashion industry interconnected ecosystem” and played an important role in the medical beauty business sector. It is of great significance to the continued expansion and stable development of the company’s medical beauty business. At the same time, under the guidance of the company’s business philosophy of “adhering to compliance operations, focusing on infrastructure construction, and practicing multiple stores in one city” in the past four years, the business scale of the above-mentioned six institutions has achieved rapid development, and their operating performance has grown steadily year by year. Industry competition Strength and brand influence have been further enhanced. In order to further strengthen the control of existing institutions and lay the foundation for subsequent brand expansion, and enhance the company’s performance, the company plans to use Langzi Medical’s own funds to acquire all remaining minority interests in the six target companies mentioned above, achieving 100% control of them.
Langzi shares pointed out that the acquisition is another major measure to accelerate the implementation of the company’s medical aesthetics development strategy, which will help further enhance Langzi medical aesthetics’ group management and brand expansion capabilities, and further enhance Langzi Medical Beauty’s performance scale and long-term operating capabilities.
The financial report shows that in 2019, Langzi Co., Ltd. achieved operating income of 3.007 billion yuan, an increase of 12.99% over the same period last year; affected by the provision for impairment of external investment assets, the realization The operating profit was 156 million yuan, a decrease of 34.84% compared with the same period of the previous year; further affected by the increase in income tax in this period, the net profit attributable to shareholders of the listed company was 58.7787 million yuan, a decrease of 72.07% compared with the same period of the previous year.
In the first quarter of 2020, Langzi Co., Ltd. achieved total operating income of 590 million yuan, a year-on-year decrease of 18.7%; it realized a net profit loss of 3.174 million yuan attributable to the parent company, compared with 52.767 million yuan in the same period last year. Unable to maintain profitability. During the reporting period, the company’s gross profit margin was 53.7%, a decrease of 6.7 percentage points year-on-year, and the net profit margin was -3.7%, a decrease of 11.8 percentage points year-on-year.
Langzi Co., Ltd. recently stated that in the second quarter of this year, the company’s women’s clothing business increased its online marketing efforts and worked hard to reduce the adverse effects of offline terminal sales, while fully restoring medical services. The U.S. business made the company’s overall revenue and gross profit margin rebound better than expected in the second quarter, and the company’s short-term losses affected by the epidemic have eased. Langzi Shares estimates that its net profit attributable to shareholders of listed companies in the first half of the year will be a loss of 3 million to 6 million yuan, compared with a profit of 89.1253 million yuan in the same period last year. </p
